364 related articles for article (PubMed ID: 29470247)
1. Hypofibrinogenemia Is Associated With Poor Outcome and Secondary Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome in Pediatric Severe Sepsis.
Signoff JK; Fitzgerald JC; Teachey DT; Balamuth F; Weiss SL
Pediatr Crit Care Med; 2018 May; 19(5):397-405. PubMed ID: 29470247
[TBL] [Abstract][Full Text] [Related]
2. High-Volume Hemofiltration in Critically Ill Patients With Secondary Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome: A Prospective Study in the PICU.
Cui Y; Zhang YC; Kang YL; Ren YQ; Miao HJ; Wang F
Pediatr Crit Care Med; 2016 Oct; 17(10):e437-e443. PubMed ID: 27487914
[TBL] [Abstract][Full Text] [Related]
3. Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?
Demirkol D; Yildizdas D; Bayrakci B; Karapinar B; Kendirli T; Koroglu TF; Dursun O; Erkek N; Gedik H; Citak A; Kesici S; Karabocuoglu M; Carcillo JA;
Crit Care; 2012 Dec; 16(2):R52. PubMed ID: 22715953
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction/macrophage activating syndrome in critically ill children*.
Rajasekaran S; Kruse K; Kovey K; Davis AT; Hassan NE; Ndika AN; Zuiderveen S; Birmingham J
Pediatr Crit Care Med; 2014 Jun; 15(5):401-8. PubMed ID: 24583503
[TBL] [Abstract][Full Text] [Related]
5. Fulfillment status of hypertriglyceridemia and hypofibrinogenemia in children with hemophagocytic lymphohistiocytosis and risks of multiple organ dysfunction syndrome and early mortality.
Li X; Yan H; Luo T; Xiao Z; Gong L; Huang J; Zhang X; Zheng M; Yao Z; Zang P; Zhu D; Lu X
Orphanet J Rare Dis; 2022 Apr; 17(1):161. PubMed ID: 35410268
[TBL] [Abstract][Full Text] [Related]
6. Screening of hemophagocytic lymphohistiocytosis in children with severe sepsis in pediatric intensive care.
El-Sayed ZA; El-Owaidy RH; Khamis MA; Rezk AR
Sci Prog; 2021; 104(3):368504211044042. PubMed ID: 34519554
[TBL] [Abstract][Full Text] [Related]
7. Hypofibrinogenemia is an independent predictor of hemophagocytic lymphohistiocytosis in children with sepsis.
Luo X; Zhou C; Ji C; Lu C; Luo Y; Chen Z; Zhong T; Ye R; Zeng L; Luo M
Sci Rep; 2023 Oct; 13(1):17936. PubMed ID: 37863910
[TBL] [Abstract][Full Text] [Related]
8. Three Hypothetical Inflammation Pathobiology Phenotypes and Pediatric Sepsis-Induced Multiple Organ Failure Outcome.
Carcillo JA; Halstead ES; Hall MW; Nguyen TC; Reeder R; Aneja R; Shakoory B; Simon D;
Pediatr Crit Care Med; 2017 Jun; 18(6):513-523. PubMed ID: 28410274
[TBL] [Abstract][Full Text] [Related]
9. Secondary hemophagocytic lymphohistiocytosis and severe sepsis/ systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation.
Castillo L; Carcillo J
Pediatr Crit Care Med; 2009 May; 10(3):387-92. PubMed ID: 19325510
[TBL] [Abstract][Full Text] [Related]
10. Consensus-Based Guidelines for the Recognition, Diagnosis, and Management of Hemophagocytic Lymphohistiocytosis in Critically Ill Children and Adults.
Hines MR; von Bahr Greenwood T; Beutel G; Beutel K; Hays JA; Horne A; Janka G; Jordan MB; van Laar JAM; Lachmann G; Lehmberg K; Machowicz R; Miettunen P; La Rosée P; Shakoory B; Zinter MS; Henter JI
Crit Care Med; 2022 May; 50(5):860-872. PubMed ID: 34605776
[TBL] [Abstract][Full Text] [Related]
11. Etiologies and Clinical Outcomes of Patients With Secondary Hemophagocytic Lymphohistiocytosis at a Tertiary PICU.
Dao D; Xoay TD; Galeano BK; Phuc PH; Ouellette Y
Pediatr Crit Care Med; 2019 Jul; 20(7):e311-e318. PubMed ID: 31149968
[TBL] [Abstract][Full Text] [Related]
12. Macrophage Activation-Like Syndrome: A Distinct Entity Leading to Early Death in Sepsis.
Karakike E; Giamarellos-Bourboulis EJ
Front Immunol; 2019; 10():55. PubMed ID: 30766533
[TBL] [Abstract][Full Text] [Related]
13. The Use of Ferritin to Identify Critically Ill Patients With Secondary Hemophagocytic Lymphohistiocytosis.
Grangé S; Buchonnet G; Besnier E; Artaud-Macari E; Beduneau G; Carpentier D; Dehay J; Girault C; Marchalot A; Guerrot D; Tamion F
Crit Care Med; 2016 Nov; 44(11):e1045-e1053. PubMed ID: 27441901
[TBL] [Abstract][Full Text] [Related]
14. An unusual cause of multiple organ dysfunction syndrome in the pediatric intensive care unit: hemophagocytic lymphohistiocytosis.
Karapinar B; Yilmaz D; Balkan C; Akin M; Ay Y; Kvakli K
Pediatr Crit Care Med; 2009 May; 10(3):285-90. PubMed ID: 19433941
[TBL] [Abstract][Full Text] [Related]
15. Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome.
Minoia F; Bovis F; Davì S; Insalaco A; Lehmberg K; Shenoi S; Weitzman S; Espada G; Gao YJ; Anton J; Kitoh T; Kasapcopur O; Sanner H; Merino R; Astigarraga I; Alessio M; Jeng M; Chasnyk V; Nichols KE; Huasong Z; Li C; Micalizzi C; Ruperto N; Martini A; Cron RQ; Ravelli A; Horne A;
J Pediatr; 2017 Oct; 189():72-78.e3. PubMed ID: 28807357
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Factors and Long-Term Outcome in 52 Turkish Children With Hemophagocytic Lymphohistiocytosis.
Kaya Z; Bay A; Albayrak M; Kocak U; Yenicesu I; Gursel T
Pediatr Crit Care Med; 2015 Jul; 16(6):e165-73. PubMed ID: 25901543
[TBL] [Abstract][Full Text] [Related]
17. Hepatobiliary Dysfunction and Disseminated Intravascular Coagulation Increase Risk of Mortality in Pediatric Hemophagocytic Lymphohistiocytosis.
Goldman J; Desai MS; McClain KL; Tcharmtchi MH; Kennedy CE; Thompson K; Lam F; Bashir DA; Chinn IK; Goldberg BR; Allen CE; Nguyen TC
Pediatr Crit Care Med; 2018 Oct; 19(10):e522-e530. PubMed ID: 30113519
[TBL] [Abstract][Full Text] [Related]
18. Hemophagocytic Lymphohistiocytosis in a PICU of a Developing Economy: Clinical Profile, Intensive Care Needs, Outcome, and Predictors of Mortality.
Parajuli B; Angurana SK; Awasthi P; Nallasamy K; Baranwal A; Bansal A; Bansal D; Rawat A; Varma N; Jayashree M
Pediatr Crit Care Med; 2021 Jan; 22(1):e44-e57. PubMed ID: 33031348
[TBL] [Abstract][Full Text] [Related]
19. Monocytes From Patients With Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis Are Hyperresponsive to Interferon Gamma.
Pascarella A; Bracaglia C; Caiello I; Arduini A; Moneta GM; Rossi MN; Matteo V; Pardeo M; De Benedetti F; Prencipe G
Front Immunol; 2021; 12():663329. PubMed ID: 33815425
[TBL] [Abstract][Full Text] [Related]
20. Hypofibrinogenemia and Pediatric Sepsis: Another Piece of the Puzzle!
Piva JP; Garcia PCR; da Rocha TS
Pediatr Crit Care Med; 2018 May; 19(5):491-492. PubMed ID: 29727417
[No Abstract] [Full Text] [Related]
[Next] [New Search]
